Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Immuno-Oncology
16 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
PR-M07-19-NI-047
M&A
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
Immune Markers
Using Immune Markers to Identify Precancerous Cells
PAO-M06-19-NI-015
Oncology
Cancer’s New Foes—Novel Oncology Approaches in the Battle Against Cancer
PAP-Q2-2019-CL-020
Immuno-Oncology
Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium
PR-M03-19-NI-006
Immuno-Oncology
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
PR-M02-19-NI-067
Immuno-Oncology
The Immuno-Oncology Assays Market is Expected to Grow From USD 2.9 Billion in 2018 to USD 5.9 Billion by 2024, at a CAGR of 12.7%
PR-M02-19-NI-053
Immuno-oncology
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
PR-M01-19-NI-031
Immuno-oncology
Sanofi and Regeneron Immuno-oncology Collaboration Ending
PAO-M01-19-NI-012
Immuno-Oncology
PrimeVax Immuno-Oncology Receives IND Permission From FDA
PR-M01-19-NI-026
Immuno-oncology
Gilead Invests in Immuno-oncology
PAO-M01-19-NI-001
Immuno-Oncology
Immuno-oncology Development Trends and Opportunities
PR-M12-18-NI-038
Immunotherapy
Nobel Prize in Medicine Goes to Immunotherapy Developers
PAO-M10-18-NI-003
Immunotherapy
Cancer Immunotherapy Treatment Market on the Rise as R&D Increases
PR-M09-18-NI-086
Collaboration
Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics for Targeted Immuno-Oncology Investigational Drug Candidates
PR-M06-18-NI-013
Collaboration
Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
PR-M05-18-NI-103
